Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]

Core Viewpoint - The company announced that its director, Zhou Zhaocheng, plans to reduce his shareholding by selling up to 230,400 shares, which represents 0.32% of the total share capital, within three months after a 15 trading day period following the announcement [1] Summary by Categories Shareholding Information - Zhou Zhaocheng holds 921,400 shares, accounting for 1.30% of the total share capital [1] - The shares to be sold are from those issued prior to the initial public offering [1]

Group 1 - The core point of the announcement is that director Zhou Zhaocheng of Shuangqiang Technology plans to reduce his shareholding by up to 230,350 shares, which is 0.32% of the company's total share capital, within three months after a 15 trading day period from the announcement date [2][4][6] - Zhou Zhaocheng currently holds 921,402 shares, representing 1.30% of the company's total share capital [2][3] - The reduction is intended to meet personal funding needs and will be executed through centralized bidding transactions [4][6] Group 2 - The company has received a guarantee request for its subsidiary, Anji Shuangqiang Bamboo Industry Co., Ltd., with a maximum guarantee amount of 120 million yuan from China CITIC Bank [13][15] - The total guarantee amount for the company's subsidiaries is estimated at 818.5 million yuan, approved by the board and shareholders [12][18] - After this guarantee, the actual external guarantee balance provided by the wholly-owned subsidiary to the company will be 90 million yuan, accounting for 10.33% of the company's latest audited net assets [18]

Summary of Key Points Core Viewpoint - The article highlights the recent stock buyback and reduction activities of various A-share listed companies, indicating potential shifts in investor sentiment and company strategies in the market [1]. Group 1: Stock Buyback Activities - Changhong Huayi: Some directors and senior management plan to increase their shareholding in the company [2]. - Pianzihuang: The controlling shareholder has obtained a special loan commitment for a buyback of up to 450 million yuan [2]. - Gaweida: The board proposes a share repurchase plan amounting to 30 million to 35 million yuan [2]. - Changan Automobile: Plans to repurchase shares worth between 1 billion to 2 billion yuan [2]. Group 2: Stock Reduction Activities - Shengke Communication: Recently, the National Integrated Circuit Industry Investment Fund reduced its stake by 0.6% of the total share capital [2]. - Furi Technology: Shareholders plan to reduce their holdings by up to 2% of the total share capital [2]. - Pulit: Shareholders Zhou Wu and executive Li Hong plan to collectively reduce their holdings by up to 0.57% [2]. - Nankuang Group: The executive vice president plans to reduce his stake by up to 1% [2]. - Qinda Environmental Protection: Shareholder Binglun Environment plans to reduce holdings by up to 3% [2]. - Fuchuang Precision: Shareholder Guotou Chuangyi plans to reduce holdings by up to 3% [2]. - Shuangqiang Technology: Director Zhou Zhaocheng plans to reduce holdings by up to 0.32% [2]. - Debi Group: The controlling shareholder plans to reduce holdings by up to 1.92% [2]. - Jinpu Garden: Shareholders plan to reduce their stakes by 1% each [2]. - Kangsi Te: Shareholders plan to reduce their holdings [2]. - Guangda Jiabao: Shareholders plan to reduce their holdings by up to 1% [2]. - Baogang Jin: Director Yuan Xiaofeng plans to reduce holdings by up to 0.0923% [2]. - ST Lutong: Shareholders plan to reduce their holdings by up to 3.33% [2]. - Zhang Xiaoqin: Shareholder plans to reduce holdings by up to 0.31% [2]. - Yuxing Co.: Shareholder Huang Shiliu plans to reduce holdings by up to 0.22% [2]. - Guai Bao Pet: Shareholders plan to reduce their holdings by up to 1.90% [2]. - Kaipu Biological: Shareholder plans to reduce holdings by up to 3% [2]. - Jiangshan Oupai: Shareholder Wang Zhong plans to reduce holdings by up to 3% [2]. - Fuguang Co.: Shareholder plans to reduce holdings by up to 3% [2].

证券日报网讯 2月4日，双枪科技发布公告称，持有公司股份921，402股（占公司总股本比例为1.30%） 的董事周兆成先生计划在本公告披露之日起15个交易日后的3个月内通过集中竞价交易方式减持公司股 份不超过230，350股，不超过公司总股本的0.32%（公司总股本的有效计算基数为70，954，300股，即 目前总股本72，000，000股剔除公司回购专用证券账户中持有的1，045，700股）。 （编辑 任世碧） ...

证券日报网讯 2月4日，双枪科技发布公告称，截至本公告披露日，公司不存在为合并报表外的单位提 供担保，无逾期债务对应的担保余额、无涉及诉讼的担保金额及因被判决败诉而应承担的担保金额。 （文章来源：证券日报） ...

证券代码：001211 证券简称：双枪科技 公告编号：2026-004 二、担保进展情况 近日，公司与中信银行股份有限公司杭州临平支行签署了《最高额保证合同》，为 安吉双枪竹业有限公司的银行授信提供连带责任保证。具体情况如下： | 序 | 担保方 | 被担保方 | 融资机构／ | 担保金额 | 担保方式 | 担保期限 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | | | 债权人 | （万元） | | | | | | 双枪科技股份 | 安吉双枪竹业有 | 中信银行股 份有限公司 | | | 不超过 10 | | | 1 | 有限公司 | 限公司 | 杭州临平支 | 12,000 | 连带责任保证 | | 年 | | | | | 行 | | | | | 本次担保在公司已审批的担保额度范围内。 三、被担保人基本情况 双枪科技股份有限公司 关于为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、担保情况概述 双枪科技股份有限公司（以下简称"本公司"或"公司"）于 20 ...

证券代码：001211 证券简称：双枪科技 公告编号：2026-003 双枪科技股份有限公司 关于公司部分董事减持股份的预披露公告 公司董事周兆成先生保证向本公司提供的信息内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 2、股份来源：公司首次公开发行前已发行股份； 3、拟减持数量及比例 | 序号 | 股东名称 | 拟减持股份数量（股） | | 拟减持股份数量占公司总股本的比例 | | | --- | --- | --- | --- | --- | --- | | | | （不超过） | | （不超过） | | | 1 | 周兆成 | | 230,350 | | 0.32% | 特别提示： 持有双枪科技股份有限公司（以下简称"公司"）股份 921,402 股（占公司总股本比 例为 1.30%）的董事周兆成先生计划在本公告披露之日起 15 个交易日后的 3 个月内通过 集中竞价交易方式减持公司股份不超过 230,350 股，不超过公司总股本的 0.32%（公司总 股本的有效计算基数为 70,954,300 股，即目前总股本 72,0 ...

截至2026年1月30日收盘，双枪科技(001211)报收于29.3元，上涨2.52%，换手率3.25%，成交量2.18万 手，成交额6327.68万元。 当日关注点 1月30日主力资金净流入59.92万元；游资资金净流出481.39万元；散户资金净流入421.48万元。 业绩披露要点 业绩预告 双枪科技发布业绩预告，预计2025年全年归属净利润盈利850万元至1150万元；营业收入预计为15.9亿 元至16.3亿元；扣非后净利润预计盈利240万元至360万元；每股收益预计盈利0.12元至0.16元。 公司公告汇总 2025年度业绩预告 双枪科技股份有限公司预计2025年度归属于上市公司股东的净利润为850万元至1,150万元，较上年同期 下降59.54%至70.09%；扣除非经常性损益后的净利润为240万元至360万元，同比下降48.77%至 65.85%；营业收入预计为159,000万元至163,000万元，较上年同期增长。业绩下降主要由于全资子公司 补缴税款及滞纳金674.48万元计入当期损益、汇率变动导致财务费用上升，以及非经常性损益同比大幅 减少。本次业绩预告未经注册会计师审计，最终数据以2025年 ...

Group 1 - The "DT New Leaf Award" is a prestigious award aimed at discovering, showcasing, and recognizing outstanding products and companies in the bio-based industry, set to be announced at the 11th Bio-based Conference [2][59] - The first round of applications for the award will close on February 10, 2026, offering exclusive promotional opportunities for participants [2][62] - The term "New Leaf" symbolizes vitality and sustainable innovation, reflecting the award's goal to highlight pioneering forces in the bio-based sector [2] Group 2 - Over 30 listed and representative companies have registered to participate in the "2026 DT New Leaf Award," showcasing a diverse range of products and innovations [3] - Notable participating companies include Wanhua Chemical, Guanghua Weiye, and Shuangqiang Technology, each presenting their latest products in various categories [3] - The award categories include innovations in bio-based materials, key chemicals, and low-carbon solutions, with companies like Lif Biological and Heng Carbon Technology leading in their respective fields [3][11][14] Group 3 - Wanhua Chemical is recognized as a leading global chemical new materials company and has established a presence in the bio-based polyurethane industry [7] - Guanghua Weiye, a leader in 3D printing materials, plans to further its market presence with an upcoming listing on the Beijing Stock Exchange [8] - Shuangqiang Technology, known as the first publicly listed company in the bamboo industry, has signed a contract to develop bamboo-based composite materials, indicating significant market potential [9] Group 4 - Lif Biological is a global leader in PEF and FDCA, with a significant investment in a production line expected to yield 15,000 tons of FDCA annually, generating over 1 billion yuan in revenue [11] - Zhongke Guosheng has completed a 200 million yuan A-round financing and is on track to produce FDCA at a large scale by 2026 [12][13] - Heng Carbon Technology has developed a revolutionary production technology for 1,3-propanediol, achieving nearly zero carbon emissions and high purity [14] Group 5 - Companies like Jinguo Zhongju and Sugar Energy Technology are focusing on innovative bio-based materials, with significant advancements in production capabilities and product offerings [16][17] - The bio-based industry is seeing a surge in innovative solutions, with companies like Huafeng New Materials and Yutong Packaging leading the charge in developing environmentally friendly products [28][29] - The DT New Leaf Award aims to promote collaboration and resource integration across the bio-based industry, enhancing the transition to green and low-carbon solutions in various sectors [57]